HCA Healthcare, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $75.6B | $70.6B | $65.0B | $60.2B | $58.8B |
| Cash from operations | $12.6B | $10.5B | $9.4B | $8.5B | $9.0B |
| Capital expenditure | $4.9B | $4.9B | $4.7B | $4.4B | $3.6B |
| Free cash flow | $7.7B | $5.6B | $4.7B | $4.1B | $5.4B |
| Share repurchases | $10.1B | $6.0B | $3.8B | $7.0B | $8.2B |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $60.7B | $59.5B | $56.2B | $52.4B | $50.7B |
| Total debt | $46.5B | $43.0B | $39.9B | $38.4B | $34.8B |
Shares outstanding 221.8M
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.
Recent filings
- June 18, 2026 8-K
- April 30, 2026 8-K
- April 29, 2026 10-Q
- April 28, 2026 8-K
- April 27, 2026 8-K
- April 24, 2026 8-K
- February 25, 2026 8-K
- February 10, 2026 10-K